BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11435472)

  • 1. Hyperactivation of p21(ras) and the hematopoietic-specific Rho GTPase, Rac2, cooperate to alter the proliferation of neurofibromin-deficient mast cells in vivo and in vitro.
    Ingram DA; Hiatt K; King AJ; Fisher L; Shivakumar R; Derstine C; Wenning MJ; Diaz B; Travers JB; Hood A; Marshall M; Williams DA; Clapp DW
    J Exp Med; 2001 Jul; 194(1):57-69. PubMed ID: 11435472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pak1 regulates multiple c-Kit mediated Ras-MAPK gain-in-function phenotypes in Nf1+/- mast cells.
    McDaniel AS; Allen JD; Park SJ; Jaffer ZM; Michels EG; Burgin SJ; Chen S; Bessler WK; Hofmann C; Ingram DA; Chernoff J; Clapp DW
    Blood; 2008 Dec; 112(12):4646-54. PubMed ID: 18768391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rac2, a hematopoiesis-specific Rho GTPase, specifically regulates mast cell protease gene expression in bone marrow-derived mast cells.
    Gu Y; Byrne MC; Paranavitana NC; Aronow B; Siefring JE; D'Souza M; Horton HF; Quilliam LA; Williams DA
    Mol Cell Biol; 2002 Nov; 22(21):7645-57. PubMed ID: 12370311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines.
    Wandzioch E; Edling CE; Palmer RH; Carlsson L; Hallberg B
    Blood; 2004 Jul; 104(1):51-7. PubMed ID: 14996702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromin GTPase-activating protein-related domains restore normal growth in Nf1-/- cells.
    Hiatt KK; Ingram DA; Zhang Y; Bollag G; Clapp DW
    J Biol Chem; 2001 Mar; 276(10):7240-5. PubMed ID: 11080503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p21 ras and phosphatidylinositol-3 kinase are required for survival of wild-type and NF1 mutant sensory neurons.
    Klesse LJ; Parada LF
    J Neurosci; 1998 Dec; 18(24):10420-8. PubMed ID: 9852579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of the nf1 tumor suppressor gene decreases fas antigen expression in myeloid cells.
    Hiatt K; Ingram DA; Huddleston H; Spandau DF; Kapur R; Clapp DW
    Am J Pathol; 2004 Apr; 164(4):1471-9. PubMed ID: 15039234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rac is activated by erythropoietin or interleukin-3 and is involved in activation of the Erk signaling pathway.
    Arai A; Kanda E; Miura O
    Oncogene; 2002 Apr; 21(17):2641-51. PubMed ID: 11965537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and biochemical evidence that haploinsufficiency of the Nf1 tumor suppressor gene modulates melanocyte and mast cell fates in vivo.
    Ingram DA; Yang FC; Travers JB; Wenning MJ; Hiatt K; New S; Hood A; Shannon K; Williams DA; Clapp DW
    J Exp Med; 2000 Jan; 191(1):181-8. PubMed ID: 10620616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Rac-1, Rac-2, and Cdc42 by hemopoietic growth factors or cross-linking of the B-lymphocyte receptor for antigen.
    Grill B; Schrader JW
    Blood; 2002 Nov; 100(9):3183-92. PubMed ID: 12384416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nf1 regulates hematopoietic progenitor cell growth and ras signaling in response to multiple cytokines.
    Zhang YY; Vik TA; Ryder JW; Srour EF; Jacks T; Shannon K; Clapp DW
    J Exp Med; 1998 Jun; 187(11):1893-902. PubMed ID: 9607929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of postmitotic neuroretina cell proliferation by distinct Ras downstream signaling pathways.
    Peyssonnaux C; Provot S; Felder-Schmittbuhl MP; Calothy G; Eychène A
    Mol Cell Biol; 2000 Oct; 20(19):7068-79. PubMed ID: 10982823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular basis for immune dysregulation by the hyperactivated E62K mutant of the GTPase RAC2.
    Arrington ME; Temple B; Schaefer A; Campbell SL
    J Biol Chem; 2020 Aug; 295(34):12130-12142. PubMed ID: 32636302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions.
    Yang FC; Chen S; Robling AG; Yu X; Nebesio TD; Yan J; Morgan T; Li X; Yuan J; Hock J; Ingram DA; Clapp DW
    J Clin Invest; 2006 Nov; 116(11):2880-91. PubMed ID: 17053831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic evidence for convergence of c-Kit- and alpha4 integrin-mediated signals on class IA PI-3kinase and the Rac pathway in regulating integrin-directed migration in mast cells.
    Tan BL; Yazicioglu MN; Ingram D; McCarthy J; Borneo J; Williams DA; Kapur R
    Blood; 2003 Jun; 101(12):4725-32. PubMed ID: 12560232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.
    Lau N; Feldkamp MM; Roncari L; Loehr AH; Shannon P; Gutmann DH; Guha A
    J Neuropathol Exp Neurol; 2000 Sep; 59(9):759-67. PubMed ID: 11005256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak.
    Sun H; King AJ; Diaz HB; Marshall MS
    Curr Biol; 2000 Mar; 10(5):281-4. PubMed ID: 10712905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.
    Yang FC; Ingram DA; Chen S; Hingtgen CM; Ratner N; Monk KR; Clegg T; White H; Mead L; Wenning MJ; Williams DA; Kapur R; Atkinson SJ; Clapp DW
    J Clin Invest; 2003 Dec; 112(12):1851-61. PubMed ID: 14679180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for Pak protein kinases in Schwann cell transformation.
    Tang Y; Marwaha S; Rutkowski JL; Tennekoon GI; Phillips PC; Field J
    Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5139-44. PubMed ID: 9560242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperactivation of protein kinase B and ERK have discrete effects on survival, proliferation, and cytokine expression in Nf1-deficient myeloid cells.
    Donovan S; See W; Bonifas J; Stokoe D; Shannon KM
    Cancer Cell; 2002 Dec; 2(6):507-14. PubMed ID: 12498719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.